{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T06:36:42Z","timestamp":1693118202138},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sao Paulo Med. J."],"published-print":{"date-parts":[[2003]]},"abstract":"<jats:p>CONTEXT: The p16 tumor suppressor gene encodes a cyclin-dependent kinase 4 inhibitor that blocks cell division during the G1 phase of the cell cycle. Alterations in this gene have been reported for various neoplasia types, including acute lymphoblastic leukemias (ALL), especially T-cell acute lymphoblastic leukemias (ALL). OBJECTIVE: To determine probable alterations in the p16 gene in children with acute lymphoblastic leukemias using the polymerase chain reaction (PCR) and direct DNA sequencing and also to analyze event-free survival (EFS). DESIGN: Retrospective study. SETTING: Department of Child Care and Pediatrics, Faculty of Medicine of Ribeir\u00e3o Preto, Universidade Federal de S\u00e3o Paulo. PARTICIPANTS: Fifty-six children with ALL (mean age 4 years). Forty (71.43%) had B-cell and 12 (21.43%) had T-cell ALL; 4 (7.1%) were biphenotypic. SAMPLE: DNA samples were extracted from bone marrow upon diagnosis and\/or relapse. In 2 T-cell cases, DNA from cerebrospinal fluid (CSF) was analyzed. MAIN MEASUREMENTS: Deletions or nucleotide substitutions in exons 1, 2 and 3 of the p16 gene were determined by PCR and nucleotide sequencing. Event-free survival was determined by the Kaplan-Meyer and log-rank test for patients carrying normal and altered p16. RESULTS: Deletions in exon 3 were observed in five cases. Abnormal migration in PCR was observed in seven cases for exon 1, six for exon 2, and five for exon 3. Mutations in exon 1 were confirmed by direct DNA sequencing in four cases and in exon 2 in two cases. The Kaplan-Meyer survival curves and the log-rank test showed no significant differences in 5-year EFS between children with normal or altered p16, or between patients with B-ALL carrying normal or altered p16 gene. Patients with T-ALL could not be evaluated via Kaplan-Meier due to the small number of cases. CONCLUSIONS: Our results, particularly regarding deletion frequency, agree with others suggesting that deletions in the p16 are initial events in leukemia genesis. The small number of samples did not allow stablishment of correlation between childhood ALL and the p16 point mutations found in our study. Kaplan-Meier analysis revealed no significant correlation between EFS and alterations in ALL. The p16 alterations frequency observed for B and T-ALL agreed with reports from other centers.<\/jats:p>","DOI":"10.1590\/s1516-31802003000200005","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T14:53:41Z","timestamp":1114613621000},"page":"58-62","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias"],"prefix":"10.1590","volume":"121","author":[{"given":"Jos\u00e9 Alexandre Rodrigues","family":"Lemos","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Defavery","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Scrideli","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Gonzaga","family":"Tone","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02787340","article-title":"How do mutated oncogenes and tumor suppressor genes cause cancer?","volume":"15","author":"Grand\u00e9r D","year":"1998","journal-title":"Med Oncol","ISSN":"http:\/\/id.crossref.org\/issn\/1357-0560","issn-type":"print"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer: II: Cyclin D and CDK inhibitors come of age","volume":"79","author":"Hunter T","year":"1994","journal-title":"Cell","ISSN":"http:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/030098589803500601","article-title":"The cell cycle: a review","volume":"35","author":"Schafer KA","year":"1998","journal-title":"Vet Pathol","ISSN":"http:\/\/id.crossref.org\/issn\/0300-9858","issn-type":"print"},{"issue":"6494","key":"ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest","volume":"371","author":"Hannon GJ","year":"1994","journal-title":"Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"6456","key":"ref5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano M","year":"1993","journal-title":"Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng0994-27","article-title":"Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma","volume":"8","author":"Caldas C","year":"1994","journal-title":"Nat Genet","ISSN":"http:\/\/id.crossref.org\/issn\/1061-4036","issn-type":"print"},{"issue":"5170","key":"ref7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.8023167","article-title":"Rates of p16 (MTS1) mutations in primary tumors with 9p loss","volume":"265","author":"Cairns P","year":"1994","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"6473","key":"ref8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori T","year":"1994","journal-title":"Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0145-2126(99)00158-7","article-title":"Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia","volume":"24","author":"Guo SX","year":"2000","journal-title":"Leuk Res","ISSN":"http:\/\/id.crossref.org\/issn\/0145-2126","issn-type":"print"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1997.15.5.1778","article-title":"Deletions of p15 and\/or p16 genes as a poor-prognosis factor in adult T-cell leukemia","volume":"15","author":"Yamada Y","year":"1997","journal-title":"J Clin Oncol","ISSN":"http:\/\/id.crossref.org\/issn\/0732-183X","issn-type":"print"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V85.10.2685.bloodjournal85102685","article-title":"Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features","volume":"85","author":"Fizzotti M","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0145-2126(97)00007-6","article-title":"Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16\/p15 deletions","volume":"21","author":"Diccianni MB","year":"1997","journal-title":"Leuk Res","ISSN":"http:\/\/id.crossref.org\/issn\/0145-2126","issn-type":"print"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2001.02729.x","article-title":"INK4A\/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukemia: a paired study on 25 patients using real-time polymerase chain reaction","volume":"113","author":"Carter TL","year":"2001","journal-title":"Br J Haematol","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1048","issn-type":"print"},{"issue":"10","key":"ref14","first-page":"2235","article-title":"Deletions of the p16 gene in pediatric leukemia and corresponding cell lines","volume":"12","author":"Kees UR","year":"1996","journal-title":"Oncogene","ISSN":"http:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1182\/blood.V93.7.2380","article-title":"Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia","volume":"93","author":"Maloney KW","year":"1999","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"7","key":"ref16","first-page":"1104","article-title":"Homozygous deletions of p16\/MTS1 and p15\/MTS2 genes are frequent in t (1;19)-negative but not in t (1;19)-positive B precursor acute lymphoblastic leukemia in childhood","volume":"10","author":"Ohnishi H","year":"1996","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood.V85.12.3431.bloodjournal85123431","article-title":"p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia","volume":"85","author":"Rasool O","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"7","key":"ref18","first-page":"1436","article-title":"Involvement of CDKN2 (p16 INK4A\/MTS1) and p15INK4B\/MTS2 in human leukemias and lymphomas","volume":"55","author":"Otsuki T","year":"1995","journal-title":"Cancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V85.4.893.bloodjournal854893","article-title":"Deletions and rearrangements of CDKN2 in lymphoid malignancy","volume":"85","author":"Stranks G","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321","article-title":"Frequent deletion of p16INK4a\/MTS1 and p15INK4b\/MTS2 in pediatric acute lymphoblastic leukemia","volume":"85","author":"Okuda T","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311","article-title":"p16INK4A and p15INK4B gene deletions in primary leukemias","volume":"86","author":"Haidar MA","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V86.2.755.bloodjournal862755","article-title":"Analysis of a family of cyclin-dependent kinase inhibitors: p15\/MTS2\/INK4B, p16\/MTS1\/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood","volume":"86","author":"Takeuchi S","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"7","key":"ref23","first-page":"1240","article-title":"Alterations of cyclin-dependent kinase 4 inhibitor (p16 INK4A\/MTS1) gene structure and expression in acute lymphoblastic leukemias","volume":"9","author":"Delmer A","year":"1995","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"2","key":"ref24","first-page":"255","article-title":"Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias","volume":"10","author":"Iolascon A","year":"1996","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1182\/blood.V85.3.854a.bloodjournal853854a","article-title":"Homozygous MTS1 (p16INK4A) deletion in primary tumor cells of 163 leukemic patients","volume":"85","author":"Cayuela JM","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood.V87.6.2180.bloodjournal8762180","article-title":"Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia","volume":"87","author":"Cayuela JM","year":"1996","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2400814","article-title":"Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias","volume":"11","author":"Hayette S","year":"1997","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"2","key":"ref28","first-page":"249","article-title":"Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage","volume":"10","author":"Nakao M","year":"1996","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies","volume":"86","author":"Ogawa S","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V85.3.657.bloodjournal853657","article-title":"p16 gene homozygous deletions in acute lymphoblastic leukemia","volume":"85","author":"Quesnel B","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/sj.leu.2400779","article-title":"Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII","volume":"11","author":"Rubnitz JE","year":"1997","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood.V85.9.2321.bloodjournal8592321","article-title":"Frequent deletion of p16INK4a\/MTS1 and p15INK4b\/MTS2 in pediatric acute lymphoblastic leukemia","volume":"85","author":"Okuda T","year":"1995","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"issue":"4","key":"ref33","first-page":"73","article-title":"Cure of leukemia","volume":"36","author":"Brenner MK","year":"1999","journal-title":"Semin Hematol","ISSN":"http:\/\/id.crossref.org\/issn\/0037-1963","issn-type":"print"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2141.1995.tb05402.x","article-title":"CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia","volume":"91","author":"Schr\u00f6der M","year":"1995","journal-title":"Br J Haematol","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1048","issn-type":"print"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood.V89.11.4161","article-title":"Homozygous deletion of the p16\/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome","volume":"89","author":"Kees UR","year":"1997","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"ref36","series-title":"PCR 2: A practical approach","first-page":"p257","volume-title":"Mutational analysis: New mutations","author":"Michaelides K","year":"1995"},{"issue":"3","key":"ref37","first-page":"514","article-title":"In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers","volume":"55","author":"Washimi O","year":"1995","journal-title":"Cancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"7","key":"ref38","first-page":"1448","article-title":"Mutations in the p16INK4\/MTS1\/CDKN2, p15INK4B\/MTS2, and p18 genes in primary and metastatic lung cancer","volume":"55","author":"Okamoto A","year":"1995","journal-title":"Cancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"13","key":"ref39","first-page":"2756","article-title":"Mutations of p16Ink4\/CDKN2 and p15Ink4B\/MTS2 genes in biliary tract cancers","volume":"55","author":"Yoshida S","year":"1995","journal-title":"Cancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<508::AID-IJC5>3.0.CO;2-7","article-title":"Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia","volume":"74","author":"Volm M","year":"1997","journal-title":"Int J Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0020-7136","issn-type":"print"}],"container-title":["Sao Paulo Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/spmj\/v121n2\/a05v1212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T03:02:39Z","timestamp":1586228559000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-31802003000200005&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003]]}},"alternative-id":["S1516-31802003000200005"],"URL":"https:\/\/doi.org\/10.1590\/s1516-31802003000200005","relation":{},"ISSN":["1516-3180"],"issn-type":[{"value":"1516-3180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}